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The 2013–2016 Ebola epidemic in West Africa chal-
lenged traditional international mechanisms for pub-
lic health team mobilisation to control outbreaks. 
Consequently, in February 2016, the European Union 
(EU) launched the European Medical Corps (EMC), a 
mechanism developed in collaboration with the World 
Health Organization (WHO) to rapidly deploy teams 
and equipment in response to public health emergen-
cies inside and outside the EU. Public Health Teams 
(PHTs), a component of the EMC, consist of experts 
in communicable disease prevention and control 
from participating countries and the European Centre 
for Disease Prevention and Control (ECDC), to sup-
port affected countries and WHO in risk assessment 
and outbreak response. The European Commission’s 
Directorate-General European Civil Protection and 
Humanitarian Aid Operations and Directorate-General 
Health and Food Safety, and ECDC, plan and support 
deployments. The first EMC-PHT deployment took 
place in May 2016, with a team sent to Angola for a 
yellow fever outbreak. The aims were to evaluate 
transmission risks to local populations and EU citizens 
in Angola, the risk of regional spread and importation 
into the EU, and to advise Angolan and EU authorities 
on control measures. International actors should gain 
awareness of the EMC, its response capacities and the 
means for requesting assistance.
The European Medical Corps
The Ebola virus disease epidemic in West Africa in 
2013–2016 revealed shortcomings in the organisation 
of the international response to public health emergen-
cies, such as the lack of rapidly deployable medical and 
public health experts, in addition to logistic and man-
agement challenges. Traditionally, support to outbreak 
control relies on the rapid mobilisation of non-govern-
mental organisations (NGOs) and experts to cover the 
public health dimension through the Global Outbreak 
Alert and Response Network (GOARN) mechanism. 
This mobilisation scheme has allowed the success-
ful control of Ebola outbreaks, among others, includ-
ing large outbreaks such as the one that occurred in 
Gulu, Uganda in 2000–2001 [1]. However, the scale of 
the 2013–2016 West Africa Ebola epidemic called for 
a much larger mobilisation than that readily achiev-
able through NGOs and GOARN alone [2]. On 8 August 
2014, under the International Health Regulations (IHR 
2005) the World Health Organization (WHO) Director-
General declared the Ebola epidemic in West Africa 
a Public Health Emergency of International Concern 
(PHEIC). Invoking the PHEIC, the WHO Director-General 
cited the need for a coordinated international response 
to mobilise resources to support affected countries in 
controlling the epidemic [3]. As a result, the European 
Centre for Disease Prevention and Control (ECDC) 
mobilised 89 experts for WHO, who were deployed 
as public health teams to support field operations, 
along with the mobilisation of resources through the 
Directorate-General for European Civil Protection 
and Humanitarian Aid Operations (DG ECHO) and the 
European mobile laboratories [4]. At the height of the 
Ebola crisis, Germany and France proposed the White 
Helmets initiative, establishing a reserve pool of health 
experts to be mobilised swiftly and deployed in areas 
suffering health emergencies [5]. In February 2016, to 
implement the lessons learned from the 2013–2016 
Ebola outbreak and in accordance with the European 
Consensus on Humanitarian Aid [6] that sets the EU 
commitment to the fundamental principles of humani-
tarian aid and to the humanitarian imperative, the 
European Union (EU) launched the European Medical 
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Corps (EMC), enabling EU and other countries partici-
pating in the EU Civil Protection Mechanism (EUCPM) 
to rapidly deploy teams and equipment in response to 
public health emergencies and disasters with health 
and humanitarian dimensions both inside and outside 
the EU. Here we describe the implementation of the 
EMC and the first deployment of an EMC Public Health 
Team (PHT) during the 2016 yellow fever outbreak in 
Angola. We also highlight how the new EU mechanism 
contributes to the rapidly evolving structures, such as 
the emergency medical team developed in WHO and in 
other countries, that respond efficiently to global pub-
lic health threats and prevent humanitarian crises and 
health disasters.
European Emergency Response Capacity 
and European public health teams
The EMC is part of the European Emergency Response 
Capacity, established under the EUCPM. The EMC 
includes emergency medical teams, public health 
teams, mobile laboratories, medical evacuation capac-
ities and logistical support (Figure 1). The EMC’s com-
prehensive approach to dealing with medical and public 
health consequences of disasters also represents the 
EU’s contribution to the global health emergency work-
force, and is therefore developed in close collaboration 
with WHO [7,8]. By August 2016, 11 participating coun-
tries had offered teams and equipment to the EMC.
European PHTs are one of the main components of the 
EMC and aim to provide teams of experts in prevention 
and control of communicable diseases to support 
activities in the affected country, under the overall 
coordination of the national authorities of the affected 
countries and WHO. PHTs must have the capacity to 
be deployed rapidly to assess public health risks and 
needs related to a health emergency, or to support 
response operations. PHTs are assembled ad hoc with 
public health experts from participating countries and 
ECDC. These teams can therefore serve to support 
WHO rapid response teams dealing with public health 
events of international concern. The mechanism to 
deploy PHTs follows the approach set up for deploying 
EUCPM teams, and gives the European Commission, 
including its various services that are interested in a 
specific mission, e.g. DG International Cooperation and 
Development (DEVCO) and DG Research and Innovation 
(RTD) and ECDC the role of shaping the mission and 
including competent public health bodies within par-
ticipating countries in the planning of the mission. The 
mechanism is activated by a request for assistance by 
an EU country, a third country or a United Nations (UN) 
agency; the European Commission (EC) can also pro-
pose activating the mechanism to affected countries 
or to WHO. Whether or not the request for assistance 
comes from WHO, communication and coordination 
with WHO starts immediately. ECDC and the EC clarify 
the terms of reference for the mission.
ECDC defines the expert profiles needed, e.g. clini-
cal, epidemiological and microbiological expertise, 
language skills, knowledge of the mission setting, 
on which basis a request for experts for the mission 
is circulated to participating countries through the EC 
and ECDC networks. Participating countries propose 
experts for the mission; ECDC reviews and shortlists 
the proposed experts, the EC accepts and confirms 
the list of experts, and proposes them to the request-
ing authority, or WHO if the mission is a joint effort 
(for joint missions, WHO may also be involved in the 
process of expert selection). The European PHT is then 
deployed with the Emergency Response Coordination 
Centre (ERCC) of DG ECHO covering the logistical and 
financial needs of the mission. ECDC provides technical 
and scientific leadership during the preparations and 
during the mission.
A security briefing is organised by ERCC before depar-
ture; the experts deployed fall under the security rules 
of DG ECHO and are covered by special insurance while 
on mission, contracted by the EC. The EU delegation 
in the country of the deployment helps the PHT with 
on-the-spot logistical assistance and knowledge of 
the local health context. Additional support on health 
policies and context of the mission can be provided by 
regional DG ECHO staff. The PHT reports during its mis-
sion to the national authority, WHO or the organisation 
that requested the deployment, and also to the ERCC 
and ECDC. At the end of the mission the team has to 
deliver a technical report [9].
Figure 1
Response assets under the European Medical Corps
























ECDC: European Centre for Disease Prevention and Control; TAST: 
Technical Assistance Support Team.
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The first European Medical Corps Public 
Health Team mission to assess the yellow 
fever epidemic in Angola
The Republic of Angola experienced an epidemic of 
yellow fever starting in December 2015. On 22 January 
2016, the IHR focal point for Angola notified WHO of the 
ongoing yellow fever epidemic. During the epidemic, all 
18 provinces of the country reported suspected cases 
with 14 provinces reporting also confirmed cases. By 
30 April 2016 (when the EMC mission was approved), 
the Angolan Ministry of Health (MoH) had reported 
2,023 cases and 258 deaths [10]. In response to the 
epidemic, a large-scale vaccination campaign was 
launched [11]. However, the vaccination efforts were 
hampered by lack of vaccine at the international level 
and by logistical constraints in Angola [12-14].
Rationale for the mission
According to WHO estimates, 34 countries in Africa and 
13 in Central and South America have conditions suit-
able for local (autochthonous) yellow fever transmis-
sion [15]. During the 2015–2016 epidemic in Angola the 
spread of confirmed cases of yellow fever from Angola 
to China, Kenya and the Democratic Republic of the 
Congo was documented, highlighting the potential for 
further international spread [14]. Although yellow fever 
has never been transmitted by the local Aedes species 
in south-east Asia, susceptible human populations and 
Aedes aegypti mosquito vectors are present, and an 
epidemic of yellow fever would have devastating con-
sequences in the non-immune human population.
A risk assessment published by ECDC on 25 March 2016 
considered the risk of importation of the virus into the 
European competent vector population through virae-
mic travellers to be limited [16]. However, it was noted 
that the level of evidence available from different 
sources reporting on this epidemic did not provide a 
robust basis for the risk assessment.
In view of the alarming situation in Angola, and consid-
ering that the competent vector Aedes aegypti is pre-
sent in some areas of Europe and the EU (e.g. the island 
of Madeira, the Overseas Countries and Territories and 
Outermost Regions of the EU and the Black Sea region 
of Europe), the EC and ECDC saw added value in send-
ing a team of public health experts to Angola. This 
mission was the first deployment of an EMC PHT and 
was organised with the support of the Government of 
Angola and in close collaboration with WHO, the EU 
Delegation in Angola and field partners.
Mission objectives
The objectives of the mission were to advise authori-
ties in Angola and in the EU on appropriate public 
health measures and to evaluate the risk to European 
citizens residing in or visiting Angola, the risk of further 
regional spread and of importation into areas of the EU 
where competent vectors are present. These objec-
tives involved liaising with WHO and all those already 
deployed in the field to better understand the situa-
tion and review the information available concerning 
the epidemiological characteristics of the yellow fever 
epidemic in Angola, describing the characteristics of 
cases, at-risk groups, the dynamic of the epidemic, 
areas with local transmission and vaccine coverage.
Organising the mission
Upon the proposal from the EU, the Government of the 
Republic of Angola requested an assessment mission, 
which was initiated by the EC and ECDC. The deploy-
ment of the expert team took place within the EUCPM 
framework. The ERCC organised the deployment of the 
team and ensured coordination with other EU services. 
ECDC provided scientific and technical leadership, 
providing terms of reference before the start of the 
mission and epidemiological support during the mis-
sion and the report preparation. The EC Directorate-
General Health and Food Safety (DG SANTE) supported 
the mission, bringing experience in health policies for 
the prevention and control of health threats. The EU 
Delegation in Angola provided essential logistical sup-
port, background and contact information.
Figure 2
Institutions participating in the first European Medical 
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DG DEVCO: Directorate-General International Cooperation and 
Development; DG ECHO: Directorate-General European Civil 
Protection and Humanitarian Aid Operations; DG RTD: Directorate-
General Research and Innovation; DG SANTE: Directorate-General 
Health and Food Safety; ECDC: European Centre for Disease 
Prevention and Control.
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Composition of the European public health 
team and coordination with other teams
The team included experts from ECDC, DG ECHO and 
three EU countries (Germany, Belgium and Portugal) and 
consisted of a team leader (ECDC), two epidemiologists 
(ECDC and Robert Koch Institute, Postgraduate Training 
for Applied Epidemiology, Germany), a vector-borne 
disease epidemiologist expert (Antwerp Institute of 
Tropical Medicine, Belgium), a clinical expert (Hospital 
de Egas Moniz– Centro Hospitalar de Lisboa Ocidental, 
Portugal), a public health expert (DG ECHO, European 
Commission, Mercator Fellowship, Germany), an ERCC 
liaison officer (DG ECHO, European Commission) and a 
health expert based in the Democratic Republic of the 
Congo (DRC) (DG ECHO, European Commission) (Figure 
2).
The mission objectives were addressed through meet-
ings with senior public health officials from the MoH 
and the national public health directorate of Angola, 
clinicians from public hospitals in Angola, the WHO 
incident manager, the WHO country representative and 
other WHO officials, medical staff, entomologists and 
vector-control technicians from the Cuban Cooperation 
team (permanently based in Angola), epidemiologists 
from the United States (US) Centers for Disease Control 
and Prevention (CDC), experts from the Chinese Center 
for Disease Control and Prevention, medical and other 
staff from Médecins sans Frontières, and UN staff. The 
available epidemiological information was reviewed 
and discussed with the partners in the field.
Field visits in Luanda and two other provinces (Huambo 
and Huila) included visits to healthcare facilities (hos-
pitals, primary care centres), provincial and municipal 
health authorities, public health activities (vaccination 
campaigns, risk communication, vector control) and 
the international airport of Luanda (Figure 3).
Outputs of the mission
A technical mission report [12] was written and rapidly 
shared with DG ECHO, DG SANTE, the Angolan MoH 
and WHO, and made publicly available on the ECDC 
website. Furthermore, the findings from the mission 
were reflected in the first update of the ECDC rapid risk 
assessment on the outbreaks of yellow fever in Angola, 
DRC and Uganda [17].
The team concluded that at the time of the mission all 
regions in Angola should be considered as areas at 
high risk of transmission of yellow fever. Large urban 
areas and the Angolan northern provinces, includ-
ing the exclave of Cabinda, represented a significant 
risk for international spread. The risk of importation in 
other countries, including the EU, could be successfully 
mitigated through the effective implementation of the 
recommendation of the IHR emergency committee on 
19 May 2016 to screen at points of entry and exit for 
proof of yellow fever vaccination in the affected coun-
tries [18].
The mission report included recommendations on 
a wide field of topics such as surveillance, clinical 
management of suspected yellow fever cases, labora-
tory capacities, vaccination campaigns, vector-control 
activities and travel-related measures.
Discussion and conclusion
In creating and deploying the PHT, the EU imple-
mented one of the main lessons learned from the 
Figure 3
European Medical Corps Public Health Team mission to Angola timeline
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IHR focal point for 
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ECDC: European Centre for Disease Prevention and Control; EMC: European Medical Corps; ERCC: Emergency Response Coordination Centre; 
EU: European Union; IHR: International Health Regulations; MoH: Ministry of Health; PHT: Public Health Team; RRA: Rapid Risk Assessment; 
WHO: World Health Organization.
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2013–2016 Ebola epidemic, where public health 
expertise provided crucial support to the outbreak 
response, and complied with the European Consensus 
on Humanitarian Aid. The new mechanism demon-
strated the ability to rapidly deploy public health 
experts selected for the objectives and context of the 
mission. Each team is selected from a pool of experts 
from participating countries with complementary pro-
fessional profiles as well as language expertise fitting 
the needs of the deployment. DG ECHO’s ERCC is able 
to provide timely assistance during both the organisa-
tion and the deployment phase. In this regard, PHTs 
can be assembled to respond to a wide variety of sce-
narios and can be deployed at all stages of a health 
crisis, including supporting early-stage capacity build-
ing or needs assessment. PHTs can also provide guid-
ance and advice to EU humanitarian and development 
actors, and enhance knowledge for EU internal prepar-
edness purposes. These practices can maximise the 
benefits brought to the affected countries, limiting the 
usual challenges associated with an external interven-
tion. The joint planning process between DG ECHO, DG 
SANTE and ECDC fosters coordination and cooperation 
at the EU level, including other EU services that may be 
involved if needed.
Ensuring that EU public health experts who may be 
sent on a PHT mission are sufficiently trained is an 
important challenge. The variety of outbreaks that may 
be faced by the PHT does not allow a standard training 
of the whole pool, but requires additional mechanisms 
for rapid training before deployment. To this end, and 
to ensure good understanding and coherence of PHT 
deployments, training a pool of selected team leaders 
may also be pursued in the future.
The role of EMC PHT is to work synergistically with WHO 
and the MoH of countries affected by a health emer-
gency in assessment and response activities. Close 
collaboration with all partner organisations in the field 
is an essential principle in EMC’s involvement in these 
activities.
The experts deployed in the first EMC PHT mission were 
able to address the main mission objectives: to trans-
late their field observations into recommendations for 
strengthening containment activities in Angola and to 
refine the assessment of the risk for importation in the 
EU.
The mission occurred 4 months after the declaration 
of the outbreak; future deployments of EMC PHT could 
occur at an earlier time point to allow for timely threat 
assessment and prompt implementation of response 
measures. These missions may need to be linked to 
follow-up actions by the EMC and partner organisa-
tions such as deployment of further experts based on 
the areas of need identified during the assessment 
mission.
The Angola mission was a relatively short assessment 
mission, and while the team cooperated with all stake-
holders, it was not integrated within the response 
structure. For future response deployments, coordi-
nation structures and working arrangements have to 
be developed with WHO and GOARN, as well as the 
government and response actors in the affected coun-
try. Moreover, cooperation with other EMC assets 
like Emergency Medical Teams or mobile laboratories 
should be fostered. An option could be to embed pub-
lic health experts within Emergency Medical Teams. 
PHTs should also participate in international prepared-
ness training and exercises, and the scenarios for such 
activities should reflect possible health dimension of 
the event. Awareness of the EMC, its response capaci-
ties and the means for requesting assistance should be 
increased among international actors to ensure infor-
mation exchange and timely activation.
The ad hoc assembled PHT is one concept in a fast 
developing field. Similarly to the EU, WHO and par-
ticipating countries are undergoing reforms as a result 
of the Ebola crisis and developing new capacities [19-
22]. PHTs, along with other EMC assets like the mobile 
laboratories and the medical evacuation capacities, 
are expected to provide GOARN, WHO rapid response 
teams and other partners with the invaluable opportu-
nity to have highly flexible teams of qualified experts 
rapidly available for emergency deployment through 
one single easy-to-activate mechanism. It will be inter-
esting to observe how these new mechanisms will 
evolve and influence the development and deployment 
of public health expertise in the future.
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